Key Points
- CAO Alexis Gil II sold 2,781 shares of Integral Ad Science at an average price of $10.28 on Dec. 2, reducing his stake by 1.99% to 136,840 shares (worth about $1.41M).
- The sale is part of a string of recent insider dispositions — including 25,901 shares on Sept. 24, 3,527 on Oct. 3 and 1,992 on Oct. 2 — signaling notable insider selling activity over the past months.
- Integral Ad Science shares trade around $10.28 with a market cap of about $1.72B; the company missed Q3 EPS estimates ($0.07 vs. $0.09) but beat on revenue, and analysts have an average rating of Hold with a $11.52 consensus target.
Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) CAO Alexis Gil II sold 2,781 shares of the business's stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $10.28, for a total value of $28,588.68. Following the completion of the transaction, the chief accounting officer directly owned 136,840 shares of the company's stock, valued at approximately $1,406,715.20. This trade represents a 1.99% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Alexis Gil II also recently made the following trade(s):
- On Friday, October 3rd, Alexis Gil II sold 3,527 shares of Integral Ad Science stock. The stock was sold at an average price of $10.18, for a total value of $35,904.86.
- On Thursday, October 2nd, Alexis Gil II sold 1,992 shares of Integral Ad Science stock. The shares were sold at an average price of $10.18, for a total transaction of $20,278.56.
- On Wednesday, September 24th, Alexis Gil II sold 25,901 shares of Integral Ad Science stock. The stock was sold at an average price of $10.18, for a total transaction of $263,672.18.
Integral Ad Science Trading Up 0.0%
Shares of NASDAQ IAS traded up $0.01 during midday trading on Thursday, reaching $10.28. 8,703 shares of the stock were exchanged, compared to its average volume of 1,594,158. The stock has a 50 day moving average price of $10.22 and a 200-day moving average price of $9.04. The company has a market capitalization of $1.72 billion, a P/E ratio of 36.70, a P/E/G ratio of 1.52 and a beta of 1.59. Integral Ad Science Holding Corp. has a 52-week low of $6.26 and a 52-week high of $11.43.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.02). The firm had revenue of $154.36 million for the quarter, compared to analysts' expectations of $149.18 million. Integral Ad Science had a net margin of 7.91% and a return on equity of 4.45%. On average, analysts forecast that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.
Institutional Trading of Integral Ad Science
Hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of Integral Ad Science by 0.5% in the first quarter. Vanguard Group Inc. now owns 9,090,229 shares of the company's stock valued at $73,267,000 after purchasing an additional 41,683 shares during the period. Sunriver Management LLC lifted its holdings in Integral Ad Science by 8.0% in the 2nd quarter. Sunriver Management LLC now owns 8,822,914 shares of the company's stock worth $73,318,000 after buying an additional 656,140 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Integral Ad Science by 10.0% in the 3rd quarter. Dimensional Fund Advisors LP now owns 5,949,164 shares of the company's stock valued at $60,503,000 after buying an additional 542,771 shares during the last quarter. P2 Capital Partners LLC grew its stake in shares of Integral Ad Science by 2.1% during the second quarter. P2 Capital Partners LLC now owns 4,910,000 shares of the company's stock valued at $40,802,000 after acquiring an additional 100,000 shares in the last quarter. Finally, Corvex Management LP purchased a new stake in shares of Integral Ad Science during the first quarter worth about $21,101,000. Hedge funds and other institutional investors own 95.78% of the company's stock.
Analysts Set New Price Targets
Several analysts have commented on the company. Wall Street Zen upgraded Integral Ad Science from a "hold" rating to a "buy" rating in a report on Sunday, August 10th. Stifel Nicolaus reiterated a "hold" rating and issued a $10.30 price target (down previously from $14.00) on shares of Integral Ad Science in a report on Thursday, September 25th. Truist Financial lowered Integral Ad Science from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, September 24th. Loop Capital lowered Integral Ad Science from a "buy" rating to a "hold" rating and set a $10.30 price target for the company. in a research note on Wednesday, September 24th. Finally, Raymond James Financial cut Integral Ad Science from an "outperform" rating to a "market perform" rating in a report on Thursday, September 25th. Fourteen investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $11.52.
Read Our Latest Analysis on Integral Ad Science
About Integral Ad Science
(
Get Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
